Trial of implantable hearing aid expanded:
This article was originally published in Clinica
Symphonix Devices has expanded its 12-centre US trial of a surgical implant to aid hearing to include a second external audio processor device. Trials of the new device, the Vibrant HF soundbridge, will be conducted alongside pivotal clinical trials of the Vibrant P processor, expanding the target population for treatment to those with a high-frequency, sensorineural hearing loss. The San Jose, California-based company plans to begin trials of a further, digital external audio processor, Vibrant D, in 1999.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.